|
Esophageal and gastric cardia adenocarcinoma study
|
ZIA CP010136 - 02095
|
$19,971
|
$19,971
|
Liao, Linda
|
DCEG (NCI)
|
|
Stomach cancer in Poland
|
ZIA CP010136 - 03140
|
$11,269
|
$11,269
|
Liao, Linda
|
DCEG (NCI)
|
|
Cohort Consortium: stomach
|
ZIA CP010136 - 10454
|
$59,063
|
$59,063
|
Liao, Linda
|
DCEG (NCI)
|
|
Gastric and Esophageal Malignancies in Northern Iran (GEMINI): Case-Control Study
|
ZIA CP000185 - 10318
|
$45,269
|
$45,269
|
Abnet, Christian
|
DCEG (NCI)
|
|
The Golestan Cohort Study
|
ZIA CP000185 - 10361
|
$70,420
|
$70,420
|
Abnet, Christian
|
DCEG (NCI)
|
|
Improving Risk Stratification for Colonoscopy Screening
|
7R03CA171836-02
|
$73,761
|
$73,761
|
ADAMS, KENNETH
|
MINNESOTA STATE DEPT OF HEALTH
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
|
5U54CA163069-04
|
$1,070,836
|
$21,417
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
1R01CA195708-01A1
|
$386,158
|
$386,158
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Colon Cancer Chemoprevention by Flavonoid Silibinin
|
5R01CA112304-09
|
$277,920
|
$277,920
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
1U10CA180791-01
|
$737,200
|
$110,580
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
SPARC as a regulator of collagen signaling in Pancreatic Cancer
|
5F31CA168350-02
|
$30,041
|
$30,041
|
AGUILERA, KRISTINA
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis
|
5R01CA180149-02
|
$557,736
|
$557,736
|
AGUS, DAVID
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Studying Colonic Stem-Cell Niche Using Microengineered Gradient-Generating Device
|
1F31CA183309-01
|
$32,377
|
$32,377
|
AHMAD, ASAD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
APC Tumor Suppressor in Cell Differentiation and Death
|
5R01CA105038-09
|
$254,412
|
$254,412
|
AHMED, YASMATH
|
DARTMOUTH COLLEGE
|
|
Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk
|
1R01CA164964-01A1
|
$444,726
|
$444,726
|
AHN, JIYOUNG
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer
|
1R01CA185357-01
|
$459,341
|
$459,341
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
Elucidating the role and regulation of epithelial plasticity in metastasis
|
1F31CA177163-01A1
|
$42,676
|
$42,676
|
AIELLO, NICOLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Prediction of Pathologic Complete Response by Gene Expression Profiling in Esopha
|
5R01CA138671-05
|
$300,665
|
$300,665
|
AJANI, JAFFER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Inhibition of Hedgehog Signaling in Gli-1+Adeno CA of the Esoph or GE junction
|
5R01CA172741-02
|
$271,399
|
$271,399
|
AJANI, JAFFER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Complications of Jaw Osteoradionecrosis in Cancer Management
|
5K22CA169089-03
|
$196,344
|
$196,344
|
AKINTOYE, SUNDAY
|
UNIVERSITY OF PENNSYLVANIA
|
|
ATBC Study
|
ZIA CP010195 - 03031
|
$1,066,167
|
$53,308
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
1U10CA180790-01
|
$1,439,850
|
$215,978
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
The Partnership for Native American Cancer Prevention (2 of 2)
|
2U54CA143924-06
|
$1,374,976
|
$288,745
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Southeast Michigan Community Network Program
|
3U54CA153606-05S1
|
$100,000
|
$16,000
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Southeast Michigan Community Network Program
|
5U54CA153606-05
|
$743,260
|
$118,922
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Single-Cell Measurement of Lipid Signaling in Colorectal Cancer
|
1R01CA177993-01A1
|
$601,659
|
$601,659
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
INFLAMMATORY CHEMOKINE CCL3 IN THE TUMOR MICROENVIRONMENT LEADS TO ENHANCED ANTIT
|
1F31CA192874-01
|
$33,648
|
$33,648
|
ALLEN, FREDERICK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
|
1R01CA182076-01A1
|
$493,395
|
$493,395
|
ALLEN, PETER
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Oncogenic Disruption of Circadian Rhythm and Chronotherapy
|
1F32CA180370-01A1
|
$55,094
|
$55,094
|
ALTMAN, BRIAN
|
UNIVERSITY OF PENNSYLVANIA
|
|
NCTN Deep South Research Consortium
|
1U10CA180855-01
|
$497,800
|
$49,780
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
HLTF gene silencing: a novel determinant of sensitivity to autophagy inhibition
|
5R01CA169134-02
|
$332,350
|
$332,350
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$709,489
|
$177,372
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
High Resolution Microendoscopy for the Management of Esophageal Neoplasia
|
1R01CA181275-01A1
|
$657,290
|
$657,290
|
ANANDASABAPATHY, SHARMILA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
|
1R01CA182872-01
|
$511,692
|
$511,692
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Bitter Melon Component and Colon Cancer Prevention
|
1R01CA190291-01
|
$544,710
|
$544,710
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Role of Id1 in adiposity, energy balance and obesity associated liver tumorigene
|
5K22CA168828-02
|
$146,259
|
$146,259
|
ANDE, SATYANARAYANA
|
GEORGIA REGENTS UNIVERSITY
|
|
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)
|
5R25CA153954-05
|
$313,570
|
$125,428
|
ANDERSON, BRADLEY
|
UNIVERSITY OF KENTUCKY
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-02
|
$2,232,714
|
$401,889
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Functions of Papillomavirus E6
|
5R01CA107394-11
|
$290,937
|
$194,928
|
ANDROPHY, ELLIOT
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
1U10CA180828-01
|
$656,150
|
$98,423
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Development of Therapeutic Approaches for Wild-Type GIST
|
ZIA BC 011494
|
$55,017
|
$27,509
|
Arnaldez, Fernanda
|
CCR (NCI)
|
|
Role of Osteoactivin in Invasion by Oral Cancers
|
5R21CA167126-02
|
$164,561
|
$164,561
|
AROSARENA, ONEIDA
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
Comprehensive SDSU/UCSD Cancer Center Partnership 1 of 2
|
3U54CA132384-05S3
|
$220,574
|
$158,813
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$390,223
|
$195,112
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Targeting of Aberrant Signaling in Patient-Derived Colorectal Cancer Models
|
5K08CA175153-02
|
$173,340
|
$173,340
|
ATREYA, CHLOE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Mouse Models to Dissect p53 Tumor Suppressor Function
|
5R01CA140875-04
|
$333,902
|
$333,902
|
ATTARDI, LAURA
|
STANFORD UNIVERSITY
|
|
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
|
1R01CA174432-01A1
|
$581,071
|
$581,071
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Dietary Risk for Colon Cancer in the Mouse
|
5R01CA151494-04
|
$276,887
|
$276,887
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
Decoding the MST1 and MST2 kinases in cellular physiology and tumor suppression
|
5R01CA136567-05
|
$575,773
|
$575,773
|
AVRUCH, JOSEPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Linking State Registry and All Payer Claims Data to Study Cancer Care
|
5R21CA172892-02
|
$61,944
|
$15,486
|
AYANIAN, JOHN
|
UNIVERSITY OF MICHIGAN
|
Total relevant funding to Digestive Diseases for this search: $423,295,398
|